Skip to content
MatchScript
Menu
Ranked #16 of 537 · Grade B−

Peter MD review

A physician-guided telehealth brand that puts GLP-1, TRT, sermorelin, NAD+, hair loss and ED on one account, with tirzepatide dosed at 60mg and semaglutide compounded with B12.

Visit Peter MD Or see your best match We may earn a commission if you start care through some of these links, at no extra cost to you. What we write about a provider is the same either way, providers we have a commercial relationship with are listed first on most boards, and every Match Score is computed from the six published factor sub-scores regardless. See our disclosure.

Semaglutide here is $149/mo starting (first-time tier) — $50 below our category median of $199.

Semaglutide
$149/mo starting (first-time tier)
Tirzepatide
$249/mo billed quarterly
Coverage
Restrictions vary by treatment — not fully disclosed
Brand-name
Compounded only
Oral option
Injectable only
Verification
Not independently listed

Best for: Patients who want more than one category of care — GLP-1 plus TRT, sermorelin or NAD+ — under a single provider relationship rather than juggling several telehealth accounts.

MatchScript's take: Our #16 pick of 537 — priced at or below the category median.

The factor breakdown

Peter MD on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.

Budget Fit71/100

Semaglutide from $149/mo starting (first-time tier) puts Budget Fit at a below-par 71 — above the budget tiers.

Speed to Start82/100

Limited or undisclosed state coverage can slow your start, for a solid 82 on Speed to Start.

Formulary Match90/100

Peter MD sticks to compounded injectables, for a strong 90 on Formulary Match.

Support Level82/100

Support lands at a solid 82 — solid, standard support.

Flexibility76/100

Flexibility scores a middling 76 — fewer levers to flex your plan.

Transparency78/100

Thinner public disclosure than the top of the ranking keeps Transparency at a middling 78.

Pricing in context

How Peter MD's monthly price sits against the category median and the cheapest provider we track.

Monthly priceSemaglutideTirzepatide
Peter MDthis providerVisit $149/mo starting (first-time tier)$50 vs median$249/mo billed quarterly$25 vs median
Category median430 tracked$199/mo$274/mo
Cheapest trackedMondaeVisit $87 per 28 days (13 charges a year)$126 per 28 days (13 charges a year)

What we found on their site

Loaded getpetermd.com on August 2026. Quoted text is theirs.

  • No price appears on the landing page. The site presents four separate treatment lines — testosterone therapy, erectile dysfunction, hair loss and weight loss — each behind its own intake.

What we like

  • The widest product line in this ranking under one account: TRT ($79/mo on a 12-month plan), sermorelin (~$195/mo on the 12-week plan), NAD+ (~$369 for an 8-10 week supply), men's hair loss and ED alongside GLP-1
  • Physician-prescribed, nationwide telehealth model, founded 2021 and based in Miami
  • Semaglutide is compounded with B12 rather than sold as the bare molecule, and returning users get a lower per-month rate ($139/mo) than first-time users
  • Tirzepatide pricing is posted plainly on the product page rather than gated behind a quiz

The caveats

  • Tirzepatide's $149 is a first-month rate only; the standing price is $249/month, billed quarterly, not monthly
  • State restrictions vary by treatment and the two sources we checked disagree — the marketing pages name only AL/ID (and AK/HI for the B12 blend), while the affiliate program's own disclosed list adds AR, CA, IA, KY, LA, MA, MI, NC and SC depending on the drug
  • Customer reviews are mixed
  • No brand-name (FDA-approved Wegovy/Zepbound) option and no oral/sublingual route

Who it's for — and who should skip it

Peter MD is for patients who want more than one category of care — GLP-1 plus TRT, sermorelin or NAD+ — under a single provider relationship rather than juggling several telehealth accounts.

Skip it if that doesn't sound like you. A closer fit may be Gala Health (Match Score 80) — or take the quiz to see where Peter MD lands for your priorities.

See every alternative to Peter MD.

How it compares to CoreAge Rx & the closest scorer

Peter MD against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.

How it comparesPeter MDthis providerCoreAge Rxour #1Gala Healthclosest scorer
Sema price$149/mo starting (first-time tier)$99/mo at every doseNot disclosed
CoverageRestrictions vary by treatment — not fully disclosedAll 50 statesAll 50 states
FormularyInjectableInjectableInjectable + brand
Match Score80 · B−91 · A−80 · B−

Peter MD, answered

Is Peter MD legit?

Peter MD is a real, operating GLP-1 telehealth program. LegitScript certification is the third-party check worth asking for — look for the seal on their site and confirm your prescriber is US-licensed at intake. Like most programs here it dispenses compounded GLP-1s, which are made by a licensed pharmacy but aren't FDA-approved.

How much does Peter MD cost?

Peter MD lists compounded semaglutide from $149/mo starting (first-time tier) and tirzepatide from $249/mo billed quarterly — below our category median of $199/mo. These are the provider's public figures at our last review (August 2026); confirm on their site, since some teaser tiers step up after month one.

Does Peter MD ship to my state?

Peter MD doesn't publish a full state list, so confirm your state is covered during intake before you pay.

Peter MD vs CoreAge Rx — which is better?

Both are in our ranking. Peter MD scores 80/100; CoreAge Rx leads our default ranking at 91/100 for its flat nationwide pricing on both molecules and easy cancellation. Peter MD can still win for you if its strengths match your priorities: it is built for patients who want more than one category of care — GLP-1 plus TRT, sermorelin or NAD+ — under a single provider relationship rather than juggling several telehealth accounts. Run the quiz to see which comes out ahead for you.

Pricing & state data last verified August 2026 from Peter MD's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on Peter MD's site. Not medical advice; see our disclosure.

Verdict · Grade B− · 80/100

Semaglutide here is $149/mo starting (first-time tier) — $50 below our category median of $199. Tirzepatide is $249/mo billed quarterly. Its strongest suit is the range of medication it offers. It is one of the top 25 programs of the 537 we rank. Best suited to patients who want more than one category of care — GLP-1 plus TRT, sermorelin or NAD+ — under a single provider relationship rather than juggling several telehealth accounts. If that is not you, Gala Health is the closest thing to it here.

Compare with other providers

Our next-best picks in default ranking order, then the 24 programs that sit nearest Peter MD here.

Compare 24 nearby providers
ProviderGo
He & She MD#1780Visit
Fella Health#1882Visit
Trimi#1979Visit
Vaylen#2081Visit
Idgie Health#2181Visit
Found#2278Visit
Enhance MD#2378Visit
Care Bare Rx#2478Visit
Effecty#2580Visit
Science & Co#2680Visit
Breeze Meds#2777Visit
Fitish#28

FDA issued FITISH a warning letter in June 2026. See FDA's warning-letter database.

79Visit
Hims & Hers#29

FDA issued Hims & Hers Health, Inc. dba Hims a warning letter in September 2025. See FDA's warning-letter database.

79Visit
Mochi Health#3079Visit
Direct GLP#3179Visit
Mondae#3279Visit
Sprout Health#33

FDA issued Sprout Health Partners LLC dba Sprout Health a warning letter in September 2025. See FDA's warning-letter database.

76Visit
System Labs#3476Visit
MyDrHank#3576Visit
bmiMD#3676Visit
Curex#37

FDA issued Curex a warning letter in September 2025. See FDA's warning-letter database.

78Visit
Invigor Medical#3878Visit
Tyde Wellness#3978Visit
REMEVi#4078Visit

Peter MD is ranked on our best semaglutide providers, best tirzepatide providers and best GLP-1 programs boards, scored on the same six factors as every other provider there.

← Back to all rankings